749879
Last Update Posted: 2019-04-29
Recruiting has ended
Females accepted | 18 Years-34 Years |
17 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Crossover Study of the Safety and PK Properties of Proellex®
Study to evaluate the PK of 25 mg and 50 mg of Proellex from 2 different suppliers in the fed and fasting states.
This study is intended to evaluate the pharmacokinetic properties of two doses (25 mg and 50 mg) of Proellex® formulated with microcrystalline cellulose (MCC) from 2 different suppliers in the fed and fasting states.
Eligibility
Relevant conditions:
Pharmacokinetics
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov